Variant of Adynamic Bone Disease in Hemodialysis Patients: Fact or Fiction?

American Journal of Kidney Diseases

Volumn 48, Issue 3, 2006, Pages 430-436

  Rocha, Lillian A ^a   Higa, Andrea ^a   Barreto, Fellype C ^a   dos Reis, Luciene M ^a   Jorgetti, Vanda ^a   Draibe, Sérgio A ^a   Carvalho, Aluizio B ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adynamic bone disease; bone biopsy; bone histomorphometry; hemodialysis; renal osteodystrophy

Indexed keywords

PARATHYROID HORMONE; PHOSPHORUS;

ADULT; ARTICLE; BONE BIOPSY; BONE DISEASE; BONE TURNOVER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FIBROSIS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; MORPHOMETRICS; OSTEOBLAST; OSTEOCLAST; OSTEOID; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; RENAL OSTEODYSTROPHY;

ADULT; AGE OF ONSET; BIOPSY; BONE AND BONES; FEMALE; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; RENAL DIALYSIS; RENAL OSTEODYSTROPHY; RETROSPECTIVE STUDIES;

EID: 33747377857     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.05.028     Document Type: Article

References (26)

1. Malluche H.H., and Faugere M.C. Renal bone disease 1990. An unmet challenge for the nephrologists. Kidney Int 38 (1990) 193-211
2. Canalis E., McCarthy T., and Centrella M. Growth factors and the regulation of bone remodeling. J Clin Invest 81 (1988) 277-281
3. Ott S.M., Maloney N.A., Coburn J.W., Alfrey A.C., and Sherrard D.J. The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. N Engl J Med 307 (1982) 709-713
4. Goodman W.G. Bone disease and aluminum. Pathogenic considerations. Am J Kidney Dis 6 (1985) 330-335
5. Moriniere P., Cohen-Solal M., Belbrik S., et al. Disappearance of aluminic bone disease in a long term asymptomatic dialysis population restricting Al(OH)3 intake. Emergence of an idiopathic adynamic bone disease not related to aluminum. Nephron 53 (1989) 93-101
6. Sherrard D.J., Hercz G., Pei Y., et al. The spectrum of bone disease in end-stage renal failure-An evolving disorder. Kidney Int 43 (1993) 436-442
7. Spasovski G.B., Bervoets A.R.J., Behets G.J.S., et al. Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis. Nephrol Dial Transplant 18 (2003) 1159-1166
8. Araujo S.M.H.A., Ambrosoni P., Lobão R.R.S., et al. The renal osteodystrophy pattern in Brazil and Uruguay. An overview. Kidney Int Suppl 85 (2003) S54-S56
9. Monier-Faugere M.C., and Malluche H.H. Trends in renal osteodystrophy. A survey from 1983 to 1995 in a total of 2248 patients. Nephrol Dial Transplant 11 suppl 3 (1996) S111-S120
10. Malluche H.H., and Monier-Faugere M.C. Risk of adynamic bone disease in dialyzed patients. Kidney Int Suppl 38 (1992) S62-S67
11. Kurz P., Monier-Faugere M.C., Bognar B., et al. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 46 (1994) 855-861
12. London G.M., Marty C., Marchais S.J., Guerin A.P., Metivier F., and Vernejoul M.C. Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephol 15 (2004) 1943-1951
13. Heaf J. Causes and consequences of adynamic bone disease. Nephron 88 (2001) 97-106
14. Cannata-Andía J.B. Adynamic bone and chronic renal failure. An overview. Am J Med Sci 320 (2000) 81-84
15. Gal-Moscovici A., and Popovtzer M.M. Parathyroid hormone-independent osteoclastic resorptive bone disease. A new variant of adynamic bone disease in haemodialysis patients. Nephrol Dial Transplant 17 (2002) 620-624
16. Malluche H.H., and Faugere M.-C. Technique of mineralized bone histology. In: Malluche H.H., and Faugere M.-C. (Eds). Atlas of Mineralized Bone Histology. (ed 1) (1986), Karger, New York, NY 26-36
17. Parfitt A.M., Drezner M.K., Glorieux F.H., et al. Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2 (1987) 595-610
18. Melsen F.D., and Mosekilde L. Tetracycline double labeling of iliac bone in 41 normal adults. Calcif Tissue Res 26 (1978) 99-102
19. Suda T., Takahashi N., Udagawa N., Jimi E., Gillespie M.T., and Martin T.J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20 (1999) 345-357
20. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis 42 suppl 3 (2003) S123-S124
21. Monier-Faugere M.C., Geng Z., Mawad Friedler R.M., Gao P., Cantor T.L., and Malluche H.H. Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients. Kidney Int 60 (2001) 1460-1468
22. Coen G., Bonucci E., Ballanti P., et al. PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease. Am J Kidney Dis 40 (2002) 348-354
23. Gejyo F., Homma N., and Arakawa M. Carpal tunnel syndrome and beta 2-microglobulin-related amyloidosis in chronic hemodialysis patients. Blood Purif 6 (1988) 125-131
24. Gejyo F., Homma M., Suzuki Y., and Arakawa M. Serum levels of beta 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis. N Engl J Med 314 (1986) 585-586
25. Onishi S., Andress D.L., Maloney N.A., Coburn J.W., and Sherrard D.J. Beta 2 microglobulin deposition in bone in chronic renal failure. Kidney Int 39 (1991) 990-995
26. Barreto F.C., Barreto D.V., Moyses R.M.A., et al. Osteoporosis in hemodialysis patients revisited by histomorphometry. A new insight into an old problem. Kidney Int 69 (2006) 1852-1857